Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.06 USD | -6.36% | -13.08% | -86.29% |
Business Summary
Number of employees: 9
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Rolke
CEO | Chief Executive Officer | 55 | 20-04-30 |
Chester Zygmont
DFI | Director of Finance/CFO | 44 | 20-04-30 |
Sandra Vedrick
IRC | Investor Relations Contact | - | - |
Robin Marsden
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
George Tidmarsh
CHM | Chairman | 64 | 20-04-30 |
Jess Roper
BRD | Director/Board Member | 59 | 20-09-30 |
James Rolke
CEO | Chief Executive Officer | 55 | 20-04-30 |
Lakhmir Chawla
BRD | Director/Board Member | 53 | 23-09-26 |
Jennifer Carver
BRD | Director/Board Member | 70 | 20-04-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,632,935 | 1,627,645 ( 99.68 %) | 0 | 99.68 % |
Company contact information
Revelation Biosciences, Inc.
4660 LaJolla Village Drive Suite 100
92122, San Diego
+650 800 3717
http://www.revbiosciences.comSector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-86.29% | 3.36M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- REVB Stock
- Company Revelation Biosciences, Inc.